In conclusion, in this prospective 2-year study, cholesterollowering therapy was associated with significant reductions in the progressive rise in serum creatinine and urinary protein excretion in 16 NIDDM patients with nephropathy. In addition to the results previously presented [1] , these observations provide further support for the potential beneficial effect of cholesterol-lowering therapy on the progression of nephropathy in patients with NIDDM. insulinaemia/glycaemia (I/G) ratio was also evaluated. Plasma glucose was measured by the glucose oxidase technique (glucose autoanalyzer, Beckman, Brea, California, USA), and HbAlc levels using automatic HPLC (Bio-Rad, Brussels, Belgium). For determination of ICA, each center sent frozen serum from all subjects to Padova University [6] . For GAD65 antibodies each center sent frozen serum to Karolinska Institute, Stockholm [7] . In each diabetes center blood samples for insulin assay were centrifuged at 4 ~ and then plasma was kept at -20 ~ until analysis. The centers then sent all plasma samples for the measurement of insulinaemia to Parma University, for radioimmunoassay (Radim kit; Rome, Italy). The inter-and intra-assay coefficients of variation were 8.2 % and 6.9 % for low values and 7.7 % and 6.0 % for high values, respectively. Since the FPIRs during IVGTT were not normally distributed, the results are expressed as percentiles. Spearman's rank test was used to correlate fasting I/G ratio with age and pubertal stage (groups 1 to 3).
A significant positive correlation was found between FPIR and chronological age (p = 0.046), in spite of the wide range of results observed. An increase in percentile values of FPIR was also found from Group 1 (prepubertal) through to Group 3 (pubertal) without significant differences between boys and girls (Table 1) . Moreover, a significant positive relationship was observed between FPIR and pubertal stages (p = 0.0043) and BMI (p = 0.0052). Also fasting I/G ratio showed a significant correlation with chronological age (p = 0.0015) and pubertal stages (p = 0.0015) in all subjects.
In our study we demonstrated that FPIR percentile values to an IVGTT increase from the younger children to the oldest group and from prepubertal to pubertal stages. Fasting I/G ratios showed a similar age-and pubertal-related pattern. Similar results have been reported by other authors who evaluated FPIR in ICA-negative first-degree relatives of IDDM patients [8] and in normal subjects [3, 4] . No significant difference was found between our boys and girls in Group i to Group 3 in terms of FPIR as Smith et al. [9] and Allen et al. [3] also reported, suggesting that gender does not affect insulinaemia changes during puberty. As children enter puberty at different chronologic ages, and their development is more related to their stage of puberty, we suggest that an accurate clinical staging of puberty rather than chronologic age may make more sense when interpreting IVGTT in young subjects at risk of IDDM followed-up throughout puberty. In fact, children may show rapid growth with pubertal development and thus a changing hormonal milieu that influences insulin sensitivity. Therefore, during the follow-up of children and adolescents at risk of IDDM it is very important to compare FPIR values taking into account pubertal stage instead of chronological age. 
